Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
10 Jan 2022 |
PSC05 |
Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021
|
|
|
07 Jan 2022 |
PSC05 |
Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021
|
|
|
07 Jan 2022 |
PSC05 |
Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021
|
|
|
05 Jan 2022 |
PSC05 |
Change of details for United Medicines Biopharma Limited as a person with significant control on 29 January 2021
|
|
|
01 Dec 2021 |
AP01 |
Appointment of David Min Chao as a director on 30 November 2021
|
|
|
30 Nov 2021 |
TM01 |
Termination of appointment of Saurabh Saha as a director on 30 November 2021
|
|
|
30 Nov 2021 |
AP04 |
Appointment of Oakwood Corporate Secretary Limited as a secretary on 30 November 2021
|
|
|
30 Nov 2021 |
AD01 |
Registered office address changed from C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3AT United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 30 November 2021
|
|
|
05 Nov 2021 |
TM02 |
Termination of appointment of the Cambridge Partnership Limited as a secretary on 1 November 2021
|
|
|
05 Nov 2021 |
CS01 |
Confirmation statement made on 21 October 2021 with updates
|
|
|
24 Oct 2021 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of alteration of Articles of Association
|
|
|
21 Oct 2021 |
MR01 |
Registration of charge 092741810003, created on 4 October 2021
|
|
|
19 Oct 2021 |
MR01 |
Registration of charge 092741810002, created on 1 October 2021
|
|
|
15 Oct 2021 |
MR01 |
Registration of charge 092741810001, created on 4 October 2021
|
|
|
01 Oct 2021 |
AA |
Total exemption full accounts made up to 31 December 2020
|
|
|
15 Apr 2021 |
AA01 |
Previous accounting period extended from 31 October 2020 to 31 December 2020
|
|
|
23 Feb 2021 |
MA |
Memorandum and Articles of Association
|
|
|
23 Feb 2021 |
RESOLUTIONS |
Resolutions
-
RES12 ‐
Resolution of varying share rights or name
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
11 Feb 2021 |
PSC02 |
Notification of United Medicines Biopharma Limited as a person with significant control on 29 January 2021
|
|
|
11 Feb 2021 |
PSC09 |
Withdrawal of a person with significant control statement on 11 February 2021
|
|
|
10 Feb 2021 |
AP01 |
Appointment of Ms Marella Thorell as a director on 29 January 2021
|
|
|
10 Feb 2021 |
AP01 |
Appointment of Mr Iqbal Hussain as a director on 29 January 2021
|
|
|
10 Feb 2021 |
TM01 |
Termination of appointment of David John Grainger as a director on 29 January 2021
|
|
|
10 Feb 2021 |
TM01 |
Termination of appointment of Francesco De Rubertis as a director on 29 January 2021
|
|
|
10 Feb 2021 |
AP01 |
Appointment of Dr Saurabh Saha as a director on 29 January 2021
|
|